{"id":"pregabalin-dose-level-1","safety":{"commonSideEffects":[{"rate":"20–30%","effect":"Dizziness"},{"rate":"15–25%","effect":"Somnolence"},{"rate":"5–10%","effect":"Dry mouth"},{"rate":"5–10%","effect":"Edema (peripheral)"},{"rate":"5–10%","effect":"Weight gain"},{"rate":"5–10%","effect":"Blurred vision"},{"rate":"3–5%","effect":"Ataxia"}]},"_chembl":{"chemblId":"CHEMBL1059","moleculeType":"Small molecule","molecularWeight":"159.23"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"By binding to presynaptic calcium channels, pregabalin decreases calcium influx and subsequently reduces the release of glutamate, norepinephrine, and substance P. This modulation of neurotransmitter release underlies its analgesic, anxiolytic, and anticonvulsant effects. The drug is thought to work through stabilization of hyperexcitable neural tissue rather than direct receptor antagonism.","oneSentence":"Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, reducing the release of excitatory neurotransmitters.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:29:58.392Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Neuropathic pain (diabetic peripheral neuropathy, postherpetic neuralgia, spinal cord injury)"},{"name":"Partial-onset seizures (adjunctive therapy)"},{"name":"Generalized anxiety disorder"},{"name":"Fibromyalgia"}]},"trialDetails":[{"nctId":"NCT07456761","phase":"NA","title":"Effect of Low-dose Pregabalin Retard (82.5 mg) Versus Standard-dose Pregabalin Retard (165 mg) on Postoperative Pain and Opioid Consumption After Elective Laparoscopic Abdominal Surgery: a Randomized, Double-blind, Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"South Egypt Cancer Institute","startDate":"2026-04","conditions":"Laparoscopic Abdominal Surgeries","enrollment":80},{"nctId":"NCT00659035","phase":"","title":"Use of Driving Tests to Evaluate Patient Performance on Oral Opioids","status":"ACTIVE_NOT_RECRUITING","sponsor":"Asokumar Buvanendran","startDate":"2008-04","conditions":"Chronic Pain","enrollment":450},{"nctId":"NCT07230197","phase":"NA","title":"The Efficacy and Safety of Pregabalin Combined With Dexmedetomidine in Patients With Fibromyalgia","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-09-30","conditions":"Fibromyalgia, Pregabalin, Dexmedetomidine","enrollment":400},{"nctId":"NCT07084753","phase":"NA","title":"Non-opioid Anesthesia Based on Thoracic Paravertebral Block During Laparoscopic Sleeve Gastrectomy","status":"NOT_YET_RECRUITING","sponsor":"IVO JURISIC","startDate":"2025-07-30","conditions":"Obese Patients, Bariatric Surgical Pain, Bariatric Surgery (Sleeve Gastrectomy )","enrollment":36},{"nctId":"NCT06990854","phase":"NA","title":"Electroacupuncture for PHN: Efficacy and Biomarker Evaluation in a Multicenter, Randomized, Sham-Controlled Trial Protocol","status":"NOT_YET_RECRUITING","sponsor":"Dexiong Han","startDate":"2025-07-01","conditions":"Postherpetic Neuralgia ( PHN )","enrollment":207},{"nctId":"NCT05640453","phase":"PHASE4","title":"Pregabalin Versus Dexmedetomidine for Delirium Treatment After Coronary Artery Bypass Grafting","status":"RECRUITING","sponsor":"Tanta University","startDate":"2022-12-15","conditions":"Pregabalin, Delirium Treatment, Coronary Artery Bypass Grafting","enrollment":70},{"nctId":"NCT07013773","phase":"PHASE1","title":"To Evaluate the Effect of Food on the Pharmacokinetics of Y-4 Tablets in Healthy Subjects","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-05-19","conditions":"Healthy Male and Female Subjects","enrollment":20},{"nctId":"NCT06766916","phase":"PHASE2","title":"Crisugabalin for Radiotherapy-Related Neuropathic Pain","status":"RECRUITING","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2025-05-07","conditions":"Neuropathic Pain","enrollment":172},{"nctId":"NCT06896994","phase":"NA","title":"Esketamine Combined Pregabalin and Duloxetine for Postherpetic Neuralgia","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-04-01","conditions":"Postherpetic Neuralgia","enrollment":150},{"nctId":"NCT06935721","phase":"PHASE1","title":"Pharmacokinetics of Y-4 Tablets With Pregabalin Capsules and Riluzole Tablets in Chinese Healthy Subject","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-03-28","conditions":"Healthy Male and Female Subjects","enrollment":10},{"nctId":"NCT06914180","phase":"NA","title":"Esketamine Combined With PRF for Trigeminal Postherpetic Neuralgia","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-04-01","conditions":"Postherpetic; Neuralgia, Trigeminal (Etiology)","enrollment":174},{"nctId":"NCT06516094","phase":"PHASE3","title":"Efficacy and Safety in the Combination of Celecoxib / Pregabalin / Vitamin B for Low Back Chronic Pain","status":"COMPLETED","sponsor":"Laboratorios Silanes S.A. de C.V.","startDate":"2024-04-11","conditions":"Chronic Low-back Pain","enrollment":192},{"nctId":"NCT03928093","phase":"PHASE3","title":"Pregabalin Treatment for RDEB Pain and Itch","status":"COMPLETED","sponsor":"The Hospital for Sick Children","startDate":"2019-08-07","conditions":"Pain, Neuropathic, Itch, Epidermolysis Bullosa","enrollment":1},{"nctId":"NCT05640479","phase":"PHASE4","title":"Pregabalin Versus Dexmedetomidine for Delirium Prevention After Cardiac Surgery","status":"COMPLETED","sponsor":"Tanta University","startDate":"2022-12-15","conditions":"Pregabalin, Dexmedetomidine, Delirium","enrollment":60},{"nctId":"NCT05804591","phase":"PHASE4","title":"Pregabalin in the Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy (LSG).","status":"RECRUITING","sponsor":"Medical University of Warsaw","startDate":"2023-04-24","conditions":"Obesity, Postoperative Pain, Postoperative Nausea and Vomiting","enrollment":90},{"nctId":"NCT06490484","phase":"PHASE2","title":"Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Diabetic Peripheral Neuropathic Pain Who Had an Inadequate Response to Pregabalin","status":"RECRUITING","sponsor":"Haisco Pharmaceutical Group Co., Ltd.","startDate":"2024-04-19","conditions":"Diabetic Peripheral Neuropathic Pain","enrollment":90},{"nctId":"NCT03325959","phase":"NA","title":"Hyperbaric Oxygen Compared to Pharmaceutical Therapies for Fibromyalgia Syndrome","status":"COMPLETED","sponsor":"Assaf-Harofeh Medical Center","startDate":"2017-03-01","conditions":"Fibromyalgia, Hyperbaric Oxygen","enrollment":76},{"nctId":"NCT04316702","phase":"NA","title":"Hyperbaric Oxygen Therapy Compared to Pharmaceutical in Fibromyalgia With Emotional Trauma","status":"COMPLETED","sponsor":"Assaf-Harofeh Medical Center","startDate":"2020-03-01","conditions":"Fibromyalgia, Emotional Trauma","enrollment":48},{"nctId":"NCT06077786","phase":"PHASE1","title":"A Trial Investigating the Pain-relieving Properties of Lu AG06474 in Healthy Adult Participants","status":"COMPLETED","sponsor":"H. Lundbeck A/S","startDate":"2023-10-13","conditions":"Healthy Participants","enrollment":26},{"nctId":"NCT06401499","phase":"PHASE4","title":"The Effect of Pregabalin and Etoricoxib on Pain Alone Versus in Combination","status":"NOT_YET_RECRUITING","sponsor":"Muhammad Ilyas","startDate":"2024-06-01","conditions":"Back Pain Lower Back Chronic","enrollment":140},{"nctId":"NCT05763550","phase":"PHASE2","title":"To Evaluate the Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Herpetic Neuralgia","status":"COMPLETED","sponsor":"Haisco Pharmaceutical Group Co., Ltd.","startDate":"2023-02-27","conditions":"Herpetic Neuralgia","enrollment":331},{"nctId":"NCT01773993","phase":"","title":"Special Investigation of Pregabalin for Fibromyalgia (Regulatory Post Marketing Commitment Plan)","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2013-02","conditions":"Pain Associated With Fibromyalgia","enrollment":534},{"nctId":"NCT01279850","phase":"","title":"Safety And Efficacy In Long Term Use Of Lyrica (Regulatory Post Marketing Commitment Plan)","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2011-08","conditions":"Neuropathic Pain","enrollment":891},{"nctId":"NCT01256593","phase":"","title":"Safety And Efficacy Of Lyrica (Regulatory Post Marketing Commitment Plan)","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2011-02-05","conditions":"Neuralgia","enrollment":3827},{"nctId":"NCT04648540","phase":"EARLY_PHASE1","title":"Multimodal Opioid-free Anesthesia Versus Opioid-based Anesthesia for Patients Undergoing Cardiac Valve Surgeries: RCT","status":"COMPLETED","sponsor":"Cairo University","startDate":"2020-12-01","conditions":"Anesthesia","enrollment":60},{"nctId":"NCT03794388","phase":"PHASE3","title":"Evaluation in the Treatment of Neuropathic Pain Post Breast Surgery","status":"COMPLETED","sponsor":"Institut Cancerologie de l'Ouest","startDate":"2019-03-19","conditions":"Breast Cancer Patient","enrollment":140},{"nctId":"NCT05389813","phase":"PHASE2, PHASE3","title":"Comparison Between Oxycodone and Pregabalin as Preemptive Analgesia","status":"UNKNOWN","sponsor":"An-Najah National University","startDate":"2021-08-15","conditions":"Anesthesia","enrollment":150},{"nctId":"NCT04766996","phase":"PHASE4","title":"PROUD Study - Preventing Opioid Use Disorders","status":"TERMINATED","sponsor":"Emory University","startDate":"2021-05-17","conditions":"Anesthesia, Opioid Use","enrollment":57},{"nctId":"NCT05829148","phase":"EARLY_PHASE1","title":"The Effect of Dexmedetomidine, Melatonin and Pregabalin","status":"UNKNOWN","sponsor":"Egymedicalpedia","startDate":"2023-05-01","conditions":"Endoscopic Sinus Surgery","enrollment":120},{"nctId":"NCT01309074","phase":"PHASE4","title":"Does Pregabalin Improve Symptoms of Anxiety in Patients With Epilepsy? A Comparison With Sertraline","status":"WITHDRAWN","sponsor":"Rush University Medical Center","startDate":"2009-11","conditions":"Epilepsy, Anxiety","enrollment":""},{"nctId":"NCT04599894","phase":"PHASE4","title":"Reducing Postoperative Side Effect of Pregabalin","status":"COMPLETED","sponsor":"The First Hospital of Jilin University","startDate":"2020-11-01","conditions":"Pain, Postoperative, Arthroplasty, Replacement, Knee, Arthroplasty, Replacement, Hip","enrollment":58},{"nctId":"NCT05509946","phase":"PHASE2, PHASE3","title":"Preemptive Analgesia Combination of Celecoxib and Pregabalin in THA","status":"UNKNOWN","sponsor":"Indonesia University","startDate":"2022-10-01","conditions":"Arthroplasty Complications, Analgetic, Celecoxib","enrollment":30},{"nctId":"NCT05292066","phase":"EARLY_PHASE1","title":"Efficacy of Pregabalin Vs Duloxetine in Diabetic Peripheral Neuropathic Pain at Variable Dose","status":"UNKNOWN","sponsor":"Aga Khan University","startDate":"2022-10","conditions":"Diabetic Peripheral Neuropathic Pain","enrollment":126},{"nctId":"NCT05478382","phase":"PHASE4","title":"Pregabalin is an Effective Treatment for Acute Postoperative Pain Following Spinal Surgery Without Major Side Effects","status":"UNKNOWN","sponsor":"Ajou University School of Medicine","startDate":"2022-10","conditions":"Postoperative Pain, Pregabalin, Spine Surgery","enrollment":132},{"nctId":"NCT01366196","phase":"NA","title":"Pregabalin for the Treatment of Pain After Posterior Spinal Fusions","status":"COMPLETED","sponsor":"Hospital for Special Surgery, New York","startDate":"2008-10","conditions":"Lumbar Spinal Fusions","enrollment":86},{"nctId":"NCT04246619","phase":"PHASE4","title":"Efficacy of Pregabalin and Duloxetine in Patients With PDPN: the Effect of Pain on Cognitive Function, Sleep and Quality of Life","status":"TERMINATED","sponsor":"KRKA","startDate":"2019-11-12","conditions":"Painful Diabetic Peripheral Neuropathy","enrollment":254},{"nctId":"NCT05248152","phase":"NA","title":"Effect of Psychosocial and Psychophysical Factors and Preemptive Analgesia on Postoperative Pain in Upper Limb Surgery","status":"UNKNOWN","sponsor":"University Medical Centre Ljubljana","startDate":"2022-01-13","conditions":"Postoperative Pain","enrollment":90},{"nctId":"NCT05181852","phase":"PHASE1","title":"Study to Investigate the Pharmacodynamic Effects of IP2015 in Healthy Male Subjects Using the Intradermal Capsaicin Model","status":"UNKNOWN","sponsor":"Initiator Pharma","startDate":"2022-01-05","conditions":"Pain","enrollment":24},{"nctId":"NCT01511640","phase":"EARLY_PHASE1","title":"Behavioral Effects of Pregabalin and Cannabis","status":"COMPLETED","sponsor":"Joshua A. Lile, Ph.D.","startDate":"2017-02-01","conditions":"Cannabis-use Disorders","enrollment":30},{"nctId":"NCT03472469","phase":"PHASE4","title":"MAST Trial: Multi-modal Analgesic Strategies in Trauma","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2018-04-02","conditions":"Nonspecific Pain Post Traumatic Injury","enrollment":1561},{"nctId":"NCT04782310","phase":"PHASE4","title":"Duloxetine vs Pregabalin for Thoracotomy Pain","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2021-03-10","conditions":"Postoperative Pain","enrollment":75},{"nctId":"NCT03348735","phase":"PHASE4","title":"Localized Neuropathic Pain: Topical Treatment Versus Systemic Treatment","status":"TERMINATED","sponsor":"University Hospital, Antwerp","startDate":"2018-12-03","conditions":"Neuropathic Pain","enrollment":33},{"nctId":"NCT00676403","phase":"PHASE2","title":"Lyrica Dose Response Study With Restless Legs Syndrome (RLS) Patients","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2008-04","conditions":"Restless Legs Syndrome","enrollment":137},{"nctId":"NCT00468845","phase":"PHASE3","title":"Study Of The Efficacy And Safety Of Pregabalin Compared To Placebo For Treatment Of Post-Surgical Pain From Hysterectomy","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2007-06","conditions":"Pain, Postoperative","enrollment":501},{"nctId":"NCT00141219","phase":"PHASE3","title":"Pregabalin Peripheral Neuropathic Pain Study","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2005-12","conditions":"Diabetic Neuropathies, Neuralgia","enrollment":241},{"nctId":"NCT00394901","phase":"PHASE3","title":"A 13-Week, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Of Pregabalin For Postherpetic Neuralgia","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2006-09","conditions":"Neuralgia, Postherpetic","enrollment":372},{"nctId":"NCT01789216","phase":"PHASE3","title":"Improving Pain Management and Long Term Outcomes Following High Energy Orthopedic Trauma (Pain Study)","status":"COMPLETED","sponsor":"Major Extremity Trauma Research Consortium","startDate":"2013-07","conditions":"Orthopaedic Fractures","enrollment":450},{"nctId":"NCT01838044","phase":"PHASE4","title":"Efficacy and Safety Study of Celecoxib and Pregabalin Compared With Celecoxib Monotherapy, in Patients With Chronic Low Back Pain Having a Neuropathic Component","status":"TERMINATED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2013-10","conditions":"Chronic Low Back Pain With a Neuropathic Component","enrollment":180},{"nctId":"NCT01455415","phase":"PHASE3","title":"Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2011-12","conditions":"Painful Diabetic Peripheral Neuropathy","enrollment":306},{"nctId":"NCT00537238","phase":"PHASE3","title":"Pregabalin Versus Levetiracetam In Partial Seizures","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2007-10","conditions":"Partial Seizures","enrollment":509},{"nctId":"NCT00280059","phase":"PHASE3","title":"Study Of The Safety And Efficacy Of Lyrica In The Treatment Of Newly Diagnosed Partial Epilepsy","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2006-08","conditions":"Epilepsy, Partial","enrollment":660},{"nctId":"NCT01727791","phase":"PHASE4","title":"A Study Of Pregabalin (Lyrica) Drug Levels In Urine, Plasma And Breast Milk Of Healthy Lactating Women","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2012-12","conditions":"Healthy Lactating Women","enrollment":10},{"nctId":"NCT01332149","phase":"PHASE3","title":"Study To Evaluate Efficacy, Safety And Tolerability Of Lyrica In Patients With Painful Diabetic Peripheral Neuropathy","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2011-07","conditions":"Diabetic Neuropathy, Painful","enrollment":626},{"nctId":"NCT00553475","phase":"PHASE3","title":"Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Of Pregabalin For Pain Associated With Diabetic Peripheral Neuropathy","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2007-10","conditions":"Diabetic Neuropathy, Painful","enrollment":314},{"nctId":"NCT00629681","phase":"PHASE4","title":"A Study of the Efficacy and Safety of Pregabalin for the Treatment of Diabetic Peripheral Neuropathy or Postherpetic Neuralgia","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2004-11","conditions":"Painful Diabetic Neuropathy and Post Herpetic Neuralgia","enrollment":217},{"nctId":"NCT00551135","phase":"PHASE3","title":"Surgical Pain After Inguinal Hernia Repair (SPAIHR)","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2008-01","conditions":"Pain, Postoperative, Hernia, Inguinal","enrollment":425},{"nctId":"NCT00645398","phase":"PHASE3","title":"A Study of the Efficacy and Safety of Pregabalin for the Treatment of Fibromyalgia","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2004-09","conditions":"Fibromyalgia","enrollment":751},{"nctId":"NCT01220180","phase":"","title":"Lyrica (Pregabalin) Korean Post Marketing Surveillance Study","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2006-07","conditions":"Epilepsy, Neuropathic Pain, Fibromyalgia","enrollment":4175},{"nctId":"NCT01432236","phase":"PHASE3","title":"A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2011-10","conditions":"Fibromyalgia","enrollment":197},{"nctId":"NCT01342198","phase":"PHASE1","title":"An Investigation of the Effects of Erythromycin on the Pharmacokinetics of the Pregabalin Controlled Release Tablet","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2011-06","conditions":"Healthy","enrollment":18},{"nctId":"NCT00610155","phase":"NA","title":"A Methodology Study Of Brain Imaging Of Pain-Killers In Post-Traumatic Neuropathic Pain Patients","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2008-09","conditions":"Pain","enrollment":18},{"nctId":"NCT00288639","phase":"PHASE4","title":"Lyrica (Pregabalin) Administered as an Add-on Therapy for Partial Seizures (LEADER).","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2005-12","conditions":"Epilepsy","enrollment":98},{"nctId":"NCT00631943","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Pregabalin (Lyrica) for the Treatment of Nerve Pain","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2004-11","conditions":"Neuralgia","enrollment":112},{"nctId":"NCT01298466","phase":"PHASE4","title":"Primary Care Identification Of Patients With Chronic Neuropathic Low Back Pain Study","status":"WITHDRAWN","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2012-02","conditions":"Low Back Pain, Neuralgia","enrollment":""},{"nctId":"NCT01443169","phase":"PHASE1","title":"A 5-treatment, Study in Healthy Volunteers to Assess The Safety, Tolerability, and Pharmacokinetics of Four Controlled Release (CR) Pregabalin Tablet Formulations and the Immediate Release (IR) Formulation Administered Fasted","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2012-03","conditions":"Healthy","enrollment":16},{"nctId":"NCT01389596","phase":"PHASE3","title":"A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2011-09-27","conditions":"Epilepsy, Partial Seizures","enrollment":295},{"nctId":"NCT01463306","phase":"PHASE3","title":"A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2012-02-21","conditions":"Epilepsy, Partial Seizures, Epilepsy, Primary Generalized Tonic-Clonic Seizures","enrollment":605},{"nctId":"NCT02072824","phase":"PHASE3","title":"A Safety, Efficacy, and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric Subjects <4 Years of Age With Partial Onset Seizures.","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2014-09-16","conditions":"Partial Onset Seizures","enrollment":175},{"nctId":"NCT01747915","phase":"PHASE3","title":"A Safety, Efficacy and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric and Adult Subjects With Primary Generalized Tonic-Clonic (i.e., Grand Mal) Seizures.","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2013-04-03","conditions":"Generalized Tonic Clonic Seizures","enrollment":219},{"nctId":"NCT02725112","phase":"PHASE1","title":"Bioavailability Study of Pregabalin Extended Release Formulation With Various Release Rates in Healthy Volunteers","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2016-02-12","conditions":"Healthy","enrollment":25},{"nctId":"NCT04647773","phase":"PHASE2, PHASE3","title":"To Evaluate the Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Diabetic Peripheral Neuropathic Pain","status":"UNKNOWN","sponsor":"Haisco Pharmaceutical Group Co., Ltd.","startDate":"2020-12-02","conditions":"Diabetic Peripheral Neuropathic Pain","enrollment":687},{"nctId":"NCT04600037","phase":"NA","title":"Pregabalin Treatment for Trigger Points","status":"COMPLETED","sponsor":"Fatih Sultan Mehmet Training and Research Hospital","startDate":"2014-04-26","conditions":"Myofascial Pain Syndrome","enrollment":40},{"nctId":"NCT02482818","phase":"PHASE1, PHASE2","title":"Efficacy of Pregabalin on Chronic Cough","status":"UNKNOWN","sponsor":"Ottawa Hospital Research Institute","startDate":"2015-09","conditions":"Cough","enrollment":40},{"nctId":"NCT03942796","phase":"NA","title":"Pregabalin Versus Pulsed Radiofrequency Ablation for Treatment of Chronic Post-thoracotomy Pain","status":"COMPLETED","sponsor":"Mansoura University","startDate":"2018-01-01","conditions":"Chronic Post-thoracotomy Pain","enrollment":30},{"nctId":"NCT04499209","phase":"PHASE1","title":"Pharmacokinetics Study of XG005 Capsule","status":"COMPLETED","sponsor":"Xgene Pharmaceutical Group","startDate":"2017-10-16","conditions":"Pain","enrollment":50},{"nctId":"NCT04265456","phase":"PHASE1","title":"A Phase 1 Study to Evaluate Pregabalin and Acetaminophen in Healthy Volunteers","status":"COMPLETED","sponsor":"Nevakar, Inc.","startDate":"2020-01-14","conditions":"Postoperative Pain","enrollment":63},{"nctId":"NCT03179345","phase":"PHASE4","title":"Simulated Driving Performance, Daytime Sedation and Cognition in Healthy Volunteers Taking Gralise, Neurontin or Lyrica","status":"COMPLETED","sponsor":"Depomed","startDate":"2015-09-24","conditions":"Healthy","enrollment":32},{"nctId":"NCT04342065","phase":"PHASE2, PHASE3","title":"Pregabalin Versus Celecoxib on Sevoflurane and Analgesic Consumption in Spine Fixation Surgery","status":"COMPLETED","sponsor":"South Egypt Cancer Institute","startDate":"2019-01-01","conditions":"Post-Operative Pain","enrollment":200},{"nctId":"NCT01271660","phase":"PHASE3","title":"A Study Evaluating the Efficacy and Safety of Pregabalin Against Frequent Muscle Cramp in Patients With Liver Cirrhosis","status":"COMPLETED","sponsor":"Seoul National University Boramae Hospital","startDate":"2011-07","conditions":"Muscle Cramp, Liver Cirrhosis","enrollment":60},{"nctId":"NCT01504412","phase":"PHASE2","title":"Asian Phase 2 Study for Treatment of Pain Associated With Diabetic Peripheral Neuropathy","status":"COMPLETED","sponsor":"Daiichi Sankyo Co., Ltd.","startDate":"2012-01","conditions":"Pain, Diabetic Peripheral Neuropathy","enrollment":450},{"nctId":"NCT02417935","phase":"PHASE4","title":"A Study of Duloxetine (LY248686) in Participants With Diabetic Peripheral Neuropathic Pain (DPNP)","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2015-04","conditions":"Diabetic Peripheral Neuropathic Pain","enrollment":304},{"nctId":"NCT02037165","phase":"PHASE1","title":"Effectiveness of Two Different Doses of BI 1026706 on the Overall Peak-to-Peak (PtP) N2/P2-component Amplitude of Laser (Somatosensory, Radiant-heat) Evoked Potentials (LEP) in UVB(Ultraviolet)-Irradiated Skin in Healthy Male Volunteers","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2014-01-21","conditions":"Healthy","enrollment":25},{"nctId":"NCT00994786","phase":"PHASE4","title":"A Study of Pregabalin (Lyrica) Augmentation in Serotonin Reuptake Inhibitor-Refractory Obsessive Compulsive Disorder","status":"COMPLETED","sponsor":"McMaster University","startDate":"2009-01","conditions":"Obsessive-Compulsive Disorder","enrollment":15},{"nctId":"NCT02285010","phase":"PHASE4","title":"Effect of Pregabalin on Post Operative Pain in Abdominal Hysterectomy Under Spinal Anesthesia With Intrathecal Morphine","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2014-11","conditions":"Post Operative Pain","enrollment":125},{"nctId":"NCT01940224","phase":"NA","title":"Evaluation of Preoperative Use of Pregabalin on Postoperative Analgesia After Laparoscopic Colorectal Surgery","status":"COMPLETED","sponsor":"Larissa University Hospital","startDate":"2013-07","conditions":"Postoperative Pain","enrollment":50},{"nctId":"NCT03211728","phase":"NA","title":"Does Perioperative Pregabalin Reduce Postoperative Pain After Arthroscopic Anterior Cruciate Ligament Reconstruction Surgery Under Spinal Anesthesia?","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2017-07-19","conditions":"Anterior Cruciate Ligament (ACL) Reconstruction","enrollment":96},{"nctId":"NCT02985216","phase":"PHASE3","title":"Clinical Trial of YHD1119 in Patients With Peripheral Neuropathic Pain","status":"COMPLETED","sponsor":"Yuhan Corporation","startDate":"2017-02-07","conditions":"Peripheral Neuropathic Pain","enrollment":371},{"nctId":"NCT03191136","phase":"PHASE1","title":"Clinical Trial to Assess the Effect of Food on the Pharmacokinetics of YHD1119 in Healthy Volunteers","status":"COMPLETED","sponsor":"Yuhan Corporation","startDate":"2017-05-10","conditions":"Peripheral Neuropathic Pain","enrollment":24},{"nctId":"NCT03407430","phase":"PHASE2","title":"Trial of Pregabalin for Granulocyte Colony-stimulating Factor (GCSF)-Induced Bone Pain","status":"TERMINATED","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2016-01-27","conditions":"Breast Cancer, Lymphoma, Pain","enrollment":11},{"nctId":"NCT01869569","phase":"PHASE2","title":"Effect of Pregabalin in Patients With Radiotherapy-related Neuropathic Pain","status":"COMPLETED","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2013-02","conditions":"Neuropathic Pain","enrollment":137},{"nctId":"NCT03512574","phase":"PHASE4","title":"Combination Effects of Pregabalin and Dexmedetomidine on Postoperative Pain","status":"COMPLETED","sponsor":"Wonkwang University Hospital","startDate":"2018-01-02","conditions":"Pain, Postoperative","enrollment":150},{"nctId":"NCT01359514","phase":"NA","title":"Mechanism-based Choice of Therapy for Neuropathic Pain","status":"COMPLETED","sponsor":"Rambam Health Care Campus","startDate":"2008-04","conditions":"Pain","enrollment":32},{"nctId":"NCT01768988","phase":"PHASE4","title":"Efficacy Of Pregabalin In The Treatment Of Pancreatic Cancer Pain. A Randomized Controlled Double-Blind, Parallel Group Study","status":"TERMINATED","sponsor":"Parc de Salut Mar","startDate":"2012-08","conditions":"Pancreatic Cancer, Visceral Pain","enrollment":20},{"nctId":"NCT00787462","phase":"NA","title":"Evaluation of Pregabalin in Idiopathic Small Fiber Neuropathy","status":"TERMINATED","sponsor":"University of Alberta","startDate":"2008-02","conditions":"Small-Fiber Neuropathy","enrollment":3},{"nctId":"NCT00929344","phase":"PHASE2","title":"Duloxetine Versus Pregabalin for Alcohol Dependence","status":"COMPLETED","sponsor":"The Scripps Research Institute","startDate":"2009-07","conditions":"Alcohol Dependence","enrollment":150},{"nctId":"NCT02952937","phase":"PHASE1","title":"Bioequivalence Study of Two Formulations of Pregabalin CR(Controlled-release) Table 300 mg","status":"COMPLETED","sponsor":"GL Pharm Tech Corporation","startDate":"2016-11","conditions":"Healthy","enrollment":24},{"nctId":"NCT02955472","phase":"PHASE1","title":"Bioequivalence Study of Two Formulations of Pregabalin CR (Controlled-release) Table 150 mg","status":"COMPLETED","sponsor":"GL Pharm Tech Corporation","startDate":"2016-11","conditions":"Healthy","enrollment":24},{"nctId":"NCT02276989","phase":"PHASE2","title":"Evaluation of a Compliance Marker in Prescription Opioid Abusers With Chronic Pain","status":"WITHDRAWN","sponsor":"Georgetown University","startDate":"2014-12","conditions":"Compliance, Chronic Pain","enrollment":""},{"nctId":"NCT01496690","phase":"PHASE4","title":"Pregablin for Anxiety-comorbidity in Patients With Schizophrenia","status":"COMPLETED","sponsor":"University of Aarhus","startDate":"2012-01","conditions":"Schizophrenia, Anxiety-comorbidity to Schizophrenia","enrollment":54},{"nctId":"NCT00977197","phase":"PHASE2","title":"A Placebo-Controlled Trial of Pregabalin (Lyrica) for Irritable Bowel Syndrome","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2010-03","conditions":"Irritable Bowel Syndrome","enrollment":85}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Lyrica Dose Level 1"],"phase":"phase_3","status":"active","brandName":"Pregabalin Dose Level 1","genericName":"Pregabalin Dose Level 1","companyName":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","companyId":"pfizer-s-upjohn-has-merged-with-mylan-to-form-viatris-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, reducing the release of excitatory neurotransmitters. Used for Neuropathic pain (diabetic peripheral neuropathy, postherpetic neuralgia, spinal cord injury), Partial-onset seizures (adjunctive therapy), Generalized anxiety disorder.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":2},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}